Literature DB >> 17664004

Expression of galectin-1, -3 (gal-1, gal-3) and the Thomsen-Friedenreich (TF) antigen in normal, IUGR, preeclamptic and HELLP placentas.

U Jeschke1, D Mayr, B Schiessl, I Mylonas, S Schulze, C Kuhn, K Friese, H Walzel.   

Abstract

BACKGROUND: Galectin-1 (gal-1) and galectin-3 (gal-3), which are members of the mammalian beta-galactoside-binding proteins, recognise preferentially (Galbeta1-4GlcNAc) sequences of several cell surface oligosaccharides. In addition, gal-1 also binds to the Thomsen-Friedenreich (TF) antigen (Galbeta1-3GalNAc-).
MATERIALS AND METHODS: Slides of frozen and paraffin-embedded placental tissue of patients with fetal intrauterine growth retardation (IUGR), preeclampsia, haemolysis, elevated liver enzymes, low platelets (HELLP) and normal term placentas were incubated with monoclonal and polyclonal antibodies against gal-1, gal-3 and TF. Staining reaction was performed with the avidin-biotinylated peroxidase complex (ABC) reagent. The intensity of the immunohistochemical reaction on the slides was analysed using a semi-quantitative score. The identity of galectin-expressing cells was analysed by using a double immunofluorescence method.
RESULTS: We demonstrated immunohistochemically that the expression of gal-1 and gal-3 on the extravillous trophoblast (EVT) is significantly up-regulated in preeclamptic and HELLP placentas and unchanged compared with normal controls in IUGR placentas. The expression of the TF antigen is significantly up-regulated in IUGR and preeclamptic extravillous trophoblast cells and unchanged in HELLP placentas compared with normal controls. In addition, the expression of gal-1 is significantly up-regulated in the decidual tissue of preeclamptic placentas and in the villous trophoblast tissue of HELLP placentas.
CONCLUSION: Our data showed that gal-1, gal-3 and TF were up-regulated on the membrane of EVT in preeclamptic placentas. In addition, the expression of gal-1 is significantly up-regulated in decidual tissue of preeclamptic placentas and villous trophoblast tissue of HELLP placentas. Taking into consideration the results of this study, we speculate that expression of both galectins and TF on the membrane of preeclamptic EVT and up-regulation of gal-1 in preeclamptic decidual cells may at least in part compensate for the apoptotic effects of maternal immune cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17664004     DOI: 10.1016/j.placenta.2007.06.006

Source DB:  PubMed          Journal:  Placenta        ISSN: 0143-4004            Impact factor:   3.481


  35 in total

1.  A primate subfamily of galectins expressed at the maternal-fetal interface that promote immune cell death.

Authors:  Nandor Gabor Than; Roberto Romero; Morris Goodman; Amy Weckle; Jun Xing; Zhong Dong; Yi Xu; Federica Tarquini; Andras Szilagyi; Peter Gal; Zhuocheng Hou; Adi L Tarca; Chong Jai Kim; Jung-Sun Kim; Saied Haidarian; Monica Uddin; Hans Bohn; Kurt Benirschke; Joaquin Santolaya-Forgas; Lawrence I Grossman; Offer Erez; Sonia S Hassan; Peter Zavodszky; Zoltan Papp; Derek E Wildman
Journal:  Proc Natl Acad Sci U S A       Date:  2009-06-02       Impact factor: 11.205

Review 2.  A potential pathophysiological role for galectins and the renin-angiotensin system in preeclampsia.

Authors:  Sandra M Blois; Ralf Dechend; Gabriela Barrientos; Anne Cathrine Staff
Journal:  Cell Mol Life Sci       Date:  2014-09-06       Impact factor: 9.261

3.  Unique trophoblast stem cell- and pluripotency marker staining patterns depending on gestational age and placenta-associated pregnancy complications.

Authors:  Maja Weber; Claudia Göhner; Sebastian San Martin; Aurelia Vattai; Stefan Hutter; Mario Parraga; Udo Jeschke; Ekkehard Schleussner; Udo R Markert; Justine S Fitzgerald
Journal:  Cell Adh Migr       Date:  2016-02-25       Impact factor: 3.405

Review 4.  Galectins: guardians of eutherian pregnancy at the maternal-fetal interface.

Authors:  Nandor Gabor Than; Roberto Romero; Chong Jai Kim; Michael R McGowen; Zoltan Papp; Derek E Wildman
Journal:  Trends Endocrinol Metab       Date:  2011-10-27       Impact factor: 12.015

5.  Galectin-3 in cord blood of term and preterm infants.

Authors:  M Demmert; K Faust; M K Bohlmann; B Tröger; W Göpel; E Herting; C Härtel
Journal:  Clin Exp Immunol       Date:  2012-02       Impact factor: 4.330

6.  Glycan characterization of pregnancy-specific glycoprotein 1 and its identification as a novel Galectin-1 ligand.

Authors:  Mirian Mendoza; Dongli Lu; Angela Ballesteros; Sandra M Blois; Kelsey Abernathy; Chiguang Feng; Charles J Dimitroff; Jonathan Zmuda; Maria Panico; Anne Dell; Gerardo R Vasta; Stuart M Haslam; Gabriela Dveksler
Journal:  Glycobiology       Date:  2020-10-21       Impact factor: 4.313

7.  Emergence of hormonal and redox regulation of galectin-1 in placental mammals: implication in maternal-fetal immune tolerance.

Authors:  Nandor Gabor Than; Roberto Romero; Offer Erez; Amy Weckle; Adi L Tarca; John Hotra; Asad Abbas; Yu Mi Han; Sung-Su Kim; Juan Pedro Kusanovic; Francesca Gotsch; Zhuocheng Hou; Joaquin Santolaya-Forgas; Kurt Benirschke; Zoltan Papp; Lawrence I Grossman; Morris Goodman; Derek E Wildman
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-29       Impact factor: 11.205

8.  Chorioamnionitis and increased galectin-1 expression in PPROM --an anti-inflammatory response in the fetal membranes?

Authors:  Nandor Gabor Than; Sung-Su Kim; Asad Abbas; Yu Mi Han; John Hotra; Adi L Tarca; Offer Erez; Derek E Wildman; Juan Pedro Kusanovic; Beth Pineles; Daniel Montenegro; Samuel S Edwin; Shali Mazaki-Tovi; Francesca Gotsch; Jimmy Espinoza; Sonia S Hassan; Zoltan Papp; Roberto Romero
Journal:  Am J Reprod Immunol       Date:  2008-10       Impact factor: 3.886

9.  Severe preeclampsia is characterized by increased placental expression of galectin-1.

Authors:  Nandor Gabor Than; Offer Erez; Derek E Wildman; Adi L Tarca; Samuel S Edwin; Asad Abbas; John Hotra; Juan Pedro Kusanovic; Francesca Gotsch; Sonia S Hassan; Jimmy Espinoza; Zoltan Papp; Roberto Romero
Journal:  J Matern Fetal Neonatal Med       Date:  2008-07

10.  Gal-1 silenced trophoblast tumor cells (BeWo) show decreased syncytium formation and different miRNA production compared to non-target silenced BeWo cells.

Authors:  Stefan Hutter; Diana M Morales-Prieto; Ulrich Andergassen; Lisa Tschakert; Christina Kuhn; Simone Hofmann; Udo R Markert; Udo Jeschke
Journal:  Cell Adh Migr       Date:  2015-09-29       Impact factor: 3.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.